Highlights
- 1
- 2Haematologica · 2022
- 3Journal of comparative effectiveness research · 2025
Publications
36 publications
Clinical research
2 studies
Active
1 study- PIMultidimensional Unmet Needs Assessments of Asian Patients with EGFR-mutated Lung Cancer at Meyer Cancer Center (NewYork-Presbyterian-Weill Cornell, Lower Manhattan, Brooklyn & Queens)Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (1)
- PINCT03318939A Phase 2 Study of Poziotinib in Patients With Non-Small Cell Lung Cancer (NSCLC), Locally Advanced or Metastatic, With EGFR or HER2 Exon 20 Insertion Mutation (ZENITH20)PHASE2 · Spectrum Pharmaceuticals, Inc. · IRB STUDY CLOSURE (as of 2023)NSCLC
External relationships
Advisory/Scientific Board Member
Rigel Pharmaceuticals, Inc.
Other Interest
AbbVie Inc. · Aptitude Health · EMD Serono, Inc. · IDEO · Janssen Biotech Inc. · Johnson & Johnson · Pfizer, Inc.
Other
MJH Life Sciences · Pfizer, Inc. · Regeneron Pharmaceuticals, Inc.